Do low T3 and higher TSH reduce hepatic LDL receptor activity and raise LDL cholesterol?

Thyroid hormones serve as central regulators of lipid metabolism, and their disruption significantly alters cardiovascular risk profiles by directly modulating how the liver processes circulating cholesterol.

Mechanistic pathways of thyroid-driven lipid regulation

• Transcriptional downregulation (T3 and SREBP-2): Active thyroid hormone (T3) directly stimulates hepatic low-density lipoprotein receptor (LDLR) gene transcription by binding to thyroid hormone response elements (TREs) on the LDLR promoter. T3 also enhances the expression and nuclear translocation of sterol regulatory element-binding protein-2 (SREBP-2), which binds to sterol regulatory elements to drive LDLR expression. Low T3 levels abolish this dual transcriptional activation.
• Receptor degradation (TSH and PCSK9): Elevated TSH binds directly to hepatic TSH receptors, stimulating the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) at both the mRNA and protein levels. Increased circulating PCSK9 promotes the rapid lysosomal degradation of cell-surface LDLR, compounding the deficit in functional receptors.

Impact on systemic lipid clearance

• Impaired clearance kinetics: The combined reduction in LDLR synthesis and accelerated receptor degradation dramatically decreases receptor-mediated endocytosis of apolipoprotein B-containing lipoproteins by hepatocytes.
• Atherogenic lipid accumulation: This clearance deficit extends the residence time of circulating LDL particles, leading directly to elevated blood levels of LDL cholesterol (LDL-C) and non-HDL cholesterol. Restoring thyroid hormone levels to normal reverses these pathologies by restoring LDLR density, accelerating clearance, and lowering serum cholesterol.

Bottom line

• Low T3 and elevated TSH synergistically reduce hepatic LDL receptor activity through impaired SREBP-2-mediated transcription and accelerated PCSK9-mediated degradation, slowing the clearance of circulating LDL and directly raising serum LDL and non-HDL cholesterol levels.